These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31504373)

  • 1. Aspirin in primary prevention of cardiovascular disease in the elderly.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose aspirin for everyone?
    Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):4-5. PubMed ID: 12425276
    [No Abstract]   [Full Text] [Related]  

  • 3. No reduction in cardiovascular risk with NSAIDs-including aspirin?
    Cleland JG
    Lancet; 2002 Jan; 359(9301):92-3. PubMed ID: 11809245
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin as preventive therapy in patients with asymptomatic vascular disease.
    Berger JS
    JAMA; 2010 Mar; 303(9):880-2. PubMed ID: 20197537
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Fortuni F; Crimi G; Gritti V; Mirizzi AM; Leonardi S; Ferrari GM
    Eur J Prev Cardiol; 2019 Oct; 26(15):1677-1679. PubMed ID: 30744399
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivaroxaban with or without aspirin for prevention of cardiovascular disease.
    Kruger PC; Eikelboom JW; Yusuf S
    Coron Artery Dis; 2018 Aug; 29(5):361-365. PubMed ID: 29346127
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin continues to attract research and debate, 115 years after its synthesis.
    Patrono C
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):251-4. PubMed ID: 24775613
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
    Godley RW; Hernandez-Vila E
    Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
    [No Abstract]   [Full Text] [Related]  

  • 10. What have we learned about using aspirin for primary prevention from the ASCEND and ARRIVE trials?
    Tousoulis D
    Cardiovasc Res; 2019 Feb; 115(2):e15-e16. PubMed ID: 30668678
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin and cyclooxygenase-2 inhibitors.
    Armstrong TA
    Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice.
    Mora S; Ames JM; Manson JE
    JAMA; 2016 Aug; 316(7):709-10. PubMed ID: 27323335
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 14. PRO: Should aspirin be used in all women older than 65 years to prevent stroke?
    Hsia J
    Prev Cardiol; 2007; 10 Suppl 4():6-11. PubMed ID: 17917525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly Population.
    Lewis JP; Riaz M; Xie S; Polekhina G; Wolfe R; Nelson M; Tonkin AM; Reid CM; Murray AM; McNeil JJ; Shuldiner AR; Lacaze P
    Clin Pharmacol Ther; 2020 Dec; 108(6):1289-1298. PubMed ID: 32562573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 17. Who should take aspirin for primary prophylaxis of coronary heart disease?
    Lowe GD
    Heart; 2001 Mar; 85(3):245-6. PubMed ID: 11179252
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
    Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
    Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary cardiovascular prevention with aspirin].
    Seguí Díaz M; Escobar C; Divisón JA
    Semergen; 2015; 41(5):279-81. PubMed ID: 25622997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.